222 related articles for article (PubMed ID: 11130094)
1. Primary treatment of cervical carcinoma. Ten years experience from one Norwegian health region.
Hagen B; Skjeldestad FE; Halvorsen T; Strickert T; Tingulstad S; Lorenz E; Onsrud M
Acta Obstet Gynecol Scand; 2000 Dec; 79(12):1093-9. PubMed ID: 11130094
[TBL] [Abstract][Full Text] [Related]
2. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY
Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up results of irradiation alone or combined with surgery in stage I-IV carcinoma of the uterine cervix.
Reinartz G; Bartsch S; Willich N
Zentralbl Gynakol; 2000; 122(6):318-23. PubMed ID: 10904995
[TBL] [Abstract][Full Text] [Related]
4. Comparison between conventional surgery and radiotherapy for FIGO stage I-II cervical carcinoma: a retrospective Japanese study.
Yamashita H; Nakagawa K; Tago M; Shiraishi K; Nakamura N; Ohtomo K; Oda K; Nakagawa S; Yasugi T; Taketani Y
Gynecol Oncol; 2005 Jun; 97(3):834-9. PubMed ID: 15894366
[TBL] [Abstract][Full Text] [Related]
5. Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years.
Covens A; Rosen B; Murphy J; Laframboise S; DePetrillo AD; Lickrish G; Colgan T; Chapman W; Shaw P
Gynecol Oncol; 2001 May; 81(2):133-7. PubMed ID: 11330939
[TBL] [Abstract][Full Text] [Related]
6. Total laparoscopic radical hysterectomy (type II-III) with pelvic lymphadenectomy in early invasive cervical cancer.
Gil-Moreno A; Puig O; Pérez-Benavente MA; Díaz B; Vergés R; De la Torre J; Martínez-Palones JM; Xercavins J
J Minim Invasive Gynecol; 2005; 12(2):113-20. PubMed ID: 15904613
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of clinical efficiency of treatment for 179 geriatric women with stage I or II cervical carcinoma].
Huang YW; Li MD; Liu FY; Li YF
Ai Zheng; 2002 Nov; 21(11):1238-40. PubMed ID: 12526224
[TBL] [Abstract][Full Text] [Related]
8. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
[TBL] [Abstract][Full Text] [Related]
9. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
[TBL] [Abstract][Full Text] [Related]
10. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
[TBL] [Abstract][Full Text] [Related]
12. [Cervical cancer before 35 years of age: epidemiological and prognostic aspects. Retrospective study of 46 cases of cervical cancer before 35 years of age in a series of 449 cases in stages IA2 and IV].
Saint-Paul MT; Brémond A; Rochet Y
J Gynecol Obstet Biol Reprod (Paris); 1993; 22(7):737-42. PubMed ID: 8308199
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer with paraaortic metastases: significance of residual paraaortic disease after surgical staging.
Kim PY; Monk BJ; Chabra S; Burger RA; Vasilev SA; Manetta A; DiSaia PJ; Berman ML
Gynecol Oncol; 1998 Jun; 69(3):243-7. PubMed ID: 9648595
[TBL] [Abstract][Full Text] [Related]
14. [Does adenocarcinoma of uterine cervix have a worse prognosis than squamous carcinoma?].
Recoules-Arche A; Rouzier R; Rey A; Villefranque V; Haie-Meder C; Pautier P; Pomel C; Lhommé C; Duvillard P; Castaigne D; Morice P
Gynecol Obstet Fertil; 2004 Feb; 32(2):116-21. PubMed ID: 15123133
[TBL] [Abstract][Full Text] [Related]
15. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
[TBL] [Abstract][Full Text] [Related]
16. The prognosis and management of cervical cancer associated with pregnancy.
Hopkins MP; Morley GW
Obstet Gynecol; 1992 Jul; 80(1):9-13. PubMed ID: 1318532
[TBL] [Abstract][Full Text] [Related]
17. Survival outcomes for women undergoing type III robotic radical hysterectomy for cervical cancer: a 3-year experience.
Cantrell LA; Mendivil A; Gehrig PA; Boggess JF
Gynecol Oncol; 2010 May; 117(2):260-5. PubMed ID: 20153886
[TBL] [Abstract][Full Text] [Related]
18. The impact of aborted radical hysterectomy in patients with cervical carcinoma.
Leath CA; Straughn JM; Estes JM; Kirby TO; Bhoola SM; Barnes MN; Kilgore LC; Alvarez RD
Gynecol Oncol; 2004 Oct; 95(1):204-7. PubMed ID: 15385133
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the prognostic impact of tumor embolization before definitive radiotherapy for cervical carcinoma.
Kapp KS; Poschauko J; Tauss J; Berghold A; Oechs A; Lahousen M; Petru E; Winter R; Kapp DS
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1399-404. PubMed ID: 16029799
[TBL] [Abstract][Full Text] [Related]
20. [Neoadjuvant chemotherapy before radiotherapy in treatment of patients with cervical carcinoma].
Li QS; Zhang XQ; Li DP; Sheng XG; Du XL; Song QQ
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):83-7. PubMed ID: 16640853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
